Bgm (BGM) Shares Outstanding (2019 - 2025)
Bgm's (BGM) quarterly Shares Outstanding (Entity) came in at $158.1 million in Q1 2025, up 636.96% year-on-year from $21.4 million in Q1 2024, and up 636.96% on a QoQ basis from $21.4 million in Q1 2024.
Bgm (BGM) Shares Outstanding (2019 - 2025) Analysis & Trends
Bgm (BGM) has 6 years of Shares Outstanding (Entity) data on file, last reported at $158.1 million in Q1 2025.
- On a quarterly basis, Shares Outstanding (Entity) rose 636.96% year-over-year to $158.1 million in Q1 2025; TTM through Mar 2025 was $158.1 million, a 636.96% increase from a year earlier, with the FY2023 full-year figure at $4.3 million, changed 0.0% from the prior year.
- Shares Outstanding (Entity) for Q1 2025 stood at $158.1 million, up from $21.4 million in the prior quarter.
- Over the last five years, Shares Outstanding (Entity) for BGM reached as high as $158.1 million in Q1 2025 and fell as low as $3.9 million in Q1 2021.
- Historically, Shares Outstanding (Entity) has averaged $28.7 million across 5 years, with a median of $4.3 million in 2022.
- Across the five-year window, Shares Outstanding (Entity) changed 0.0% in 2023 and surged 636.96% in 2025, its largest moves.
- Year by year, Shares Outstanding (Entity) stood at $3.9 million in 2021, then gained by 10.24% to $4.3 million in 2022, then changed by 0.0% to $4.3 million in 2023, then soared by 400.0% to $21.4 million in 2024, then jumped by 636.96% to $158.1 million in 2025.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $158.1 million in Q1 2025, $21.4 million in Q1 2024, and $4.3 million in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 8.98 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.16 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 422.10 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 455,871.00 |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 100.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 497.70 Mn |
| 10 | Bgm | 45.84 Mn | 37.04 Mn | - | 113.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 113.26 Mn |
| Mar 31, 2025 | 31.62 Mn |
| Sep 30, 2024 | 7.23 Mn |
| Mar 31, 2024 | 35.75 Mn |
| Sep 30, 2023 | 7.15 Mn |
| Mar 31, 2023 | 7.15 Mn |
| Sep 30, 2022 | 7.15 Mn |
| Mar 31, 2022 | 7.15 Mn |
| Sep 30, 2021 | 6.82 Mn |
| Mar 31, 2021 | 6.49 Mn |
| Sep 30, 2020 | 6.00 Mn |
| Sep 30, 2019 | 6.00 Mn |